Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Ischemia With Non-valvular Atrial Fibrillation”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableStudy completedNCT02507856
What this trial is testing

Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA

Who this might be right for
Brain Ischemia With Non-valvular Atrial FibrillationTransient Ischemic Attack With Non-valvular Atrial Fibrillation
University Hospital, Essen 10,044
Testing effectiveness (Phase 2)Study completedNCT03433235
What this trial is testing

Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Acute Ischemic Stroke
Jong Sung Kim 68
Large-scale testing (Phase 3)UnknownNCT03777631
What this trial is testing

STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study

Who this might be right for
Ischemic StrokeAtrial Fibrillation Non-Rheumatic
Nippon Medical School 251
Not applicableStudy completedNCT04099238
What this trial is testing

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

Who this might be right for
Atrial Fibrillation
Bayer 3,739
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00448214
What this trial is testing

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 448
Not applicableUnknownNCT06057467
What this trial is testing

Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF

Who this might be right for
Acute Ischemic StrokeAtrial Fibrillation
Second Affiliated Hospital, Zhejiang University, School of Medicine 2,351
Not applicableStudy completedNCT02344901
What this trial is testing

ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)

Who this might be right for
Thrombotic StrokeAtrial Fibrillation and Flutter
Muğla Sıtkı Koçman University 6,273
Not applicableUnknownNCT02356432
What this trial is testing

Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)

Who this might be right for
Ischemic StrokeAtrial Fibrillation Symptomatic
Tokai University 86
Not applicableActive Not RecruitingNCT04010955
What this trial is testing

Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

Who this might be right for
Acute Ischemic StrokeAtrial FibrillationExtracranial Atherosclerosis+5 more
Asan Medical Center 1,200
Post-approval studies (Phase 4)Study completedNCT03061006
What this trial is testing

Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
DementiaCognition DisordersCerebral Ischemic Events
Intermountain Health Care, Inc. 101
Not applicableStudy completedNCT04429646
What this trial is testing

LAMax Vs. Watchman LAAC Device for Subjects With Non-valvular AF to Reduce the Risk of Stroke

Who this might be right for
Non-valvular Atrial Fibrillation
Second Affiliated Hospital, Zhejiang University, School of Medicine 236
Not applicableStudy completedNCT03596502
What this trial is testing

Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs Warfarin)

Who this might be right for
Atrial FibrillationIschemic StrokeSystemic Embolization+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 402,764
Testing effectiveness (Phase 2)Study completedNCT00938730
What this trial is testing

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 1,280
Not applicableStudy completedNCT03568916
What this trial is testing

Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)

Who this might be right for
Atrial FibrillationIschemic StrokeSystemic Embolization+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 227,579
Large-scale testing (Phase 3)Ended earlyNCT03302494
What this trial is testing

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

Who this might be right for
Stroke
Coherex Medical 248
Not applicableStudy completedNCT05321810
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 193,565
Post-approval studies (Phase 4)Ended earlyNCT03062319
What this trial is testing

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

Who this might be right for
Ischemic StrokeAtrial FibrillationAtherothrombosis
National Hospital Organization Osaka National Hospital 321
Not applicableUnknownNCT05761704
What this trial is testing

Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Second Affiliated Hospital, Zhejiang University, School of Medicine 54
Not applicableLooking for participantsNCT04559243
What this trial is testing

Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events

Who this might be right for
Non-valvular Atrial FibrillationEmbolic Stroke
Lifetech Scientific (Shenzhen) Co., Ltd. 579
Next Page